{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:55:23Z","timestamp":1758635723138},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1007\/s11938-000-0032-9","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T17:44:12Z","timestamp":1180892652000},"page":"445-450","source":"Crossref","is-referenced-by-count":5,"title":["Hepatorenal syndrome"],"prefix":"10.1007","volume":"3","author":[{"given":"Ramon","family":"Planas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon","family":"Bataller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Rod\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"32_CR1","first-page":"3","volume-title":"Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment","author":"V Arroyo","year":"1999","unstructured":"Arroyo V, Bataller R: Historical notes on ascites in cirrosis. In Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment. Edited by Arroyo V, Gin\u00e8s P, Rod\u00e9s J, et al. Boston: Blackwell Science Inc.; 1999:3\u201313."},{"key":"32_CR2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","volume":"23","author":"V Arroyo","year":"2000","unstructured":"Arroyo V, Gin\u00e8s P, Gerbes A, et al.: Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome. Hepatology 1996, 23:164\u2013167. Review and definitions from the Consensus Conference of the International Ascites Club.","journal-title":"Hepatology"},{"key":"32_CR3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9343(70)80073-0","volume":"49","author":"M Epstein","year":"1970","unstructured":"Epstein M, Berk DP, Hollenberg NK, et al.: Renal failure in the patient with cirrhosis: the role of active vasoconstriction. Am J Med 1970, 49:175\u2013185.","journal-title":"Am J Med"},{"key":"32_CR4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1042\/cs0920433","volume":"92","author":"K Moore","year":"1997","unstructured":"Moore K: The hepatorenal syndrome. Clin Sci 1997, 92:433\u2013443.","journal-title":"Clin Sci"},{"key":"32_CR5","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","volume":"8","author":"RW Schrier","year":"1988","unstructured":"Schrier RW, Arroyo V, Bernardi M, et al.: Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988, 8:1151\u20131157. Paper with the description of the arterial vasodilation theory, which best explains the development of HRS.","journal-title":"Hepatology"},{"key":"32_CR6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","volume":"339","author":"PY Martin","year":"1998","unstructured":"Martin PY, Gin\u00e8s P, Schrier RW: Role of nitric oxide as mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 1998, 339:533\u2013541. The role of nitric oxide in hemodynamic abnormalities of cirrhosis is reviewed.","journal-title":"N Engl J Med"},{"key":"32_CR7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","volume":"105","author":"A Gin\u00e8s","year":"1993","unstructured":"Gin\u00e8s A, Escorsell A, Gin\u00e8s P, et al.: Incidence, predictive factors, and prognosis of hepatorenal syndrome in cirrhosis. Gastroenterology 1993, 105:229\u2013236.","journal-title":"Gastroenterology"},{"key":"32_CR8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00007890-199502150-00010","volume":"59","author":"TA Gonwa","year":"1995","unstructured":"Gonwa TA, Klintmalm GB, Levy M, et al.: Impact of pretransplant renal function on survival after liver transplantation. Transplantation 1995, 59:361\u2013365.","journal-title":"Transplantation"},{"key":"32_CR9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.510270107","volume":"27","author":"M Guevara","year":"1998","unstructured":"Guevara M, Gin\u00e8s P, Fern\u00e1ndez-Esparrach G, et al.: Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology 1998, 27:35\u201341.","journal-title":"Hepatology"},{"key":"32_CR10","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/hep.510300430","volume":"30","author":"V G\u00fclber","year":"1999","unstructured":"G\u00fclber V, Bilzer M, Gerbes AL: Long-term therapy and retreatment of hepatorenal s\u00edndrome type I with ornipressin and dopamine. Hepatology 1999, 30:870\u2013875.","journal-title":"Hepatology"},{"key":"32_CR11","volume-title":"Fachinformation","author":"R Glycylpressin","year":"2000","unstructured":"Glycylpressin R, Terlipressin Acetate. In Fachinformation. Kiel, Austria: Ferring Arzneimittel GmbH; 1996."},{"key":"32_CR12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","volume":"33","author":"J Uriz","year":"2000","unstructured":"Uriz J, Gin\u00e8s P, C\u00e1rdenas A, et al.: Terlipressin plus albumin infusion: An effective and safe therapy of hepatorenal syndrome. J Hepatol 2000, 33:43\u201348. A pilot study reporting the reversal of hepatorenal syndrome in 78% of the patients assessed.","journal-title":"J Hepatol"},{"key":"32_CR13","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/hep.1840220536","volume":"25","author":"ML Shiffman","year":"1995","unstructured":"Shiffman ML, Jeffers L, Hoofnagle JH, et al.: The role of transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension and its complications: a conference sponsored by the National Digestive Disease advisory board. Hepatology 1995, 25:1591\u20131597.","journal-title":"Hepatology"},{"key":"32_CR14","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJM199505043321803","volume":"332","author":"A Ochs","year":"1995","unstructured":"Ochs A, R\u00f6ssle M, Haag K, et al.: The transjugular intrahepatic portosystemic stent shunt procedure for refractory ascites. N Engl J Med 1995, 332:1192\u20131197.","journal-title":"N Engl J Med"},{"key":"32_CR15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.510270107","volume":"27","author":"M Guevara","year":"1998","unstructured":"Guevara M, Gin\u00e8s P, Bandi JC, et al.: Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome. Hepatology 1998, 27:35\u201341.","journal-title":"Hepatology"},{"key":"32_CR16","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(97)24010-9","volume":"349","author":"KA Brensing","year":"1997","unstructured":"Brensing KA, Textor J, Strunk H, et al.: Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome. Lancet 1997, 349:697\u2013698.","journal-title":"Lancet"},{"key":"32_CR17","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","volume":"29","author":"P Angeli","year":"1999","unstructured":"Angeli P, Volpin R, Gerunda G, et al.: Reversal of type I hepatorenal syndrome with the administration of midodrine and octreotide. Hepatolgy 1999, 29:1690\u20131697.","journal-title":"Hepatolgy"},{"key":"32_CR18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0168-8278(90)90106-2","volume":"11","author":"J Fevery","year":"1990","unstructured":"Fevery J, Van Custem E, Nevens F, et al.: Reversal of hepatorenal sybdrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin admnistration. J Hepatol 1990, 11:153\u2013158.","journal-title":"J Hepatol"},{"key":"32_CR19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0168-8278(05)80042-X","volume":"17","author":"A Gin\u00e8s","year":"1993","unstructured":"Gin\u00e8s A, Salmer\u00f3n JM, Gin\u00e8s P, et al.: Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure. J Hepatol 1993, 17:220\u2013226.","journal-title":"J Hepatol"},{"key":"32_CR20","first-page":"492","volume-title":"Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment","author":"V Arroyo","year":"1999","unstructured":"Arroyo V, Bataller R, Guevara M: Treatment of hepatorenal syndrome in cirrhosis. In Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment. Edited by Arroyo V, Gin\u00e8s P, Rod\u00e9s J, et al. Boston: Blackwell Science Inc.; 1999:492\u2013510."}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-000-0032-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-000-0032-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-000-0032-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:53Z","timestamp":1559437013000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-000-0032-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["32"],"URL":"https:\/\/doi.org\/10.1007\/s11938-000-0032-9","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}